Experimental epsilon-aminocaproic acid (EACA) administration in the presence of subarachnoid blood.
D000614:Aminocaproates / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D000818:Animals; D001100:Arachnoiditis / Q000209:etiology; D001693:Biological Transport, Active; D001798:Blood Proteins; D002556:Cerebrospinal Fluid Proteins; D004285:Dogs; D005260:Female; D006849:Hydrocephalus / Q000209:etiology; D007275:Injections, Intravenous; D007278:Injections, Spinal; D002542:Intracranial Embolism and Thrombosis / Q000139:chemically induced; D008297:Male; D011506:Proteins / Q000378:metabolism; D011868:Radioisotopes; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000188:drug therapy*
D000614:Aminocaproates; D001798:Blood Proteins; D002556:Cerebrospinal Fluid Proteins; D011506:Proteins; D011868:Radioisotopes